[1] | Giugliano, D., Ceriello, A., Paolisso, G., 1999, Oxidative stress and diabetic vascular complications, Diabetes Care 19, 257−267. |
[2] | Edelstein, D., Brownlee, M.,1992, Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine, Diabetes 41 , 26-29. |
[3] | Giardino, I., Fard, A.K., Hatchell, D.L., Brownlee, M., 1998, Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation and oxidant-in-duced apoptosis, Diabetes 47,1114−1120. |
[4] | Ihm, S.H., Yoo, J.H., Park, S.W., Ihm, J.,1999, Effect of aminoguanidine on lipid peroxidation instrepto-zotocininduced diabetic rats, Metabolism 48, 1141−1145. |
[5] | Taguchi, T., Sugiura, M., Hamada, Y., Miwa, I.,1999, Inhibitionof advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal, European Journal of Pharmacology 378, 283−289. |
[6] | Taguchi ,T., Sugiura, M., Hamada ,Y. Miwa, I, 1998, In Vivo Formation of a Schiff Base of Amino guanidine with Pyridoxal Phosphate, Biochemical Pharmacology 55, 1667−1671. |
[7] | Miyoshi, H., Taguchi, T., Sugiura, M., Takeuchi, M., Yanagisawa, K., Watanabe, Y., Miwa, I., Makita, Z., Koike, T., 2002, AminoguanidinePyridoxal Adduct is Superior to Aminoguanidine for Preventing Diabetic Nephropathy in Mice, Hormonal Metabolism, Res. 34, 371−377. |
[8] | Chen, A.S.,Taguchi, T., Aoyama, S., Sugiura, M., Ha-runa, M., Wang, M.W., Miwa, I., 2003, Antioxidant activity of a Schiff base of pyridoxal and aminoguanidine, Free Radical Biological Medicine, 35, 1392−1403. |
[9] | Price, D.L., Rhett, P.M., Thorpe, S.R., Baynes, J.W., 2001, Chelating Activity of Advanced Glycation Endproduct Inhibtors, Journal of Biological Chemistry, 276,48967− 48972. |
[10] | a) Leovac, V.M., Joksovic, D., Divjakovic, V., Jo-vanovic, Lj., Saranovic, Z., Pevec, A., 2007, Synthesis, spectroscopic and X-ray characterization of a cop-per (II) complex with the Schiff base derived from pyridoxal and aminoguanidine: NMR spectral studies of the ligand, Journal of Inorganic Biochemistry 101, 1094−1097. |
[11] | b) Jelic, M., Boukos , N., Lalovic, M., Romcevic, N., Leovac, M., Hadzic, B., Balos, S., Jovanovic, Lj., Slankamenac, M., Zivanov, M., Vojinovic-Jwsic, Lj., Synthesis, structure and photoluminescence properties of coper (II) and cobalt (III) complexes with pyridox-alaminoguanidine, 2013, Optical Materials, 35, 2728-2735. |
[12] | Otwinowski, Z., Minor,V., in Methods Enzymology, edited by C.W. Carter and M.R. Sweet Academic Press, New York, USA 1996. |
[13] | Nonius, B.V., Delft, The Netherlands, 1997. |
[14] | Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M.C., Polidori, G., Camalli, M., 1994, SIR 92-a program for automatic solution of crystal structures by direct methods, Journal Applyed Crystal 27, 435 |
[15] | Betteridge, P.W., Carruthers, J.R.,Cooper, R.I., Prout, J., Watkin, D.J., 2003, CRYSTAL version 12: software for guided crystal structure analysis, Journal Applyed Crystallography 36, 1487. |
[16] | Jevtovic, V., Cu, Fe, Ni and V complexes with pyridoxalsemicarbazones. Syntheses, physical and chemical properties, structural analyses and bi-ological activities, Monograph, Lambert Academic Publishing, Germany 2010. |